Reimbursement cuts and changes in urologist use of androgen deprivation therapy for prostate cancer

Keyphrases

• Academic Affiliation 33%
• Androgen Deprivation Therapy 100%
• Board Certification 11%
• Financial Incentives 33%
• Linked Database 11%
• Low Risk 11%
• Medicare 11%
• Multilevel Logistic Regression Model 11%
• Multilevel Model 11%
• Non-academic 33%
• Panel Size 11%
• Patient Panel 11%
• Patient Tumor 11%
• Potentially Inappropriate 11%
• Primary Therapy 11%
• Prostate Cancer 100%
• Reimbursement 100%
• Surveillance Epidemiology 11%
• Tumor 11%
• Urologists 100%

Medicine and Dentistry

• Androgen Deprivation Therapy 100%
• Hope 11%
• Incentive 33%
• Logistic Regression Analysis 11%
• Medicare 11%
• Neoplasm 22%
• Prostate Cancer 100%
• Surveillance, Epidemiology, and End Results 11%
• Urologist 100%

Psychology

• Board Certification 50%
• Medicare 50%
• Prostate Cancer 100%
• Regression Model 50%